Perceptive Advisors’s LianBio American Depositary Shares LIAN Stock Holding History

Perceptive Advisors’s Portfolio LIAN Stock Details LIAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-57,558,451	Closed	-$257M	–	127
2023 Q4	$257M	Hold	57,558,451	–	–	5.74%	3
2023 Q3	$85.8M	Hold	57,558,451	–	–	2.86%	7
2023 Q2	$131M	Hold	57,558,451	–	–	3.8%	3
2023 Q1	$113M	Hold	57,558,451	–	–	3.33%	8
2022 Q4	$94.4M	Hold	57,558,451	–	–	2.65%	9
2022 Q3	$115M	Buy	57,558,451 +998,240	+2%	+$2.39M	3.34%	6
2022 Q2	$122M	Buy	56,560,211 +240,251	+0.4%	+$816K	3.83%	6
2022 Q1	$209M	Hold	56,319,960	–	–	4.19%	4
2021 Q4	$347M	Buy	+56,319,960	New	+$643M	5.35%	3

Other funds holding LIAN

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Perceptive Advisors's LIAN Position: Q1 2024 in Review

Perceptive Advisors sold out of LianBio American Depositary Shares (LIAN) in Q1 2024, closing a stake of 57,558,451 shares — an estimated $257M sold.

Perceptive Advisors first reported a position in LIAN in Q4 2021 and held it in 9 quarters. The position peaked at $347M in Q4 2021. 3 funds tracked by Wall St. Rank hold LIAN as of Q1 2024.

Perceptive Advisors reported no remaining LianBio American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Perceptive Advisors sold 57,558,451 LianBio American Depositary Shares shares in Q1 2024, an estimated $257M.
Perceptive Advisors first reported a position in LianBio American Depositary Shares in Q4 2021 and held it in 9 quarters.
Perceptive Advisors's LianBio American Depositary Shares position peaked at $347M in Q4 2021.
3 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2024.

Based on Perceptive Advisors's 13F filing for Q1 2024, filed 15 May 2024.